Summary
In vitro platelet aggregation has been studied in 29 normal subjects and 35 diabetic patients with retinopathy by conventional aggregating agents and by a new technique which evaluates the platelet shape change. — Platelet shape change, expressed as % light transmission variation induced by the addition of ADP (10 μmol/l) in calcium-deprived platelet rich plasma, was determined. Significant differences were found between the controls (12.6±0.7%) and the 35 diabetics (15.6±1.0%, p <0.02) and between controls and the subgroup of patients with proliferative retinopathy (17.3±1.1%, n=15, p<0.001). Platelet aggregation induced by ADP, collagen and ristocetin did not show significant differences between normal and diabetic subjects. — The shape change is the physiological early phase of platelet aggregation and is related to energy requiring mechanisms. As yet unexplored metabolic abnormalities at this stage could account for previously described platelet abnormalities in diabetes.
Article PDF
Similar content being viewed by others
References
Heath H, Bridgen W D, Canever J V, Pollock J, Hunter P R, Kelsey J, Bloom A (1971) Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia 7:308–311
Leone G, Bizzi B, Accorrà F, Boni P (1974) Functional aspects of platelets in diabetes mellitus. In: Caprino L, Rossi F C (eds) Platelet aggregation and drugs. Academic Press, New York, p 49–61
Bensoussan D, Levy-Toledano S L, Passa P, Caen J, Canivet J (1975) Platelet hyperaggregation and increased level of von Willebrand factor in diabetics with retinopathy. Diabetologia 11:307–312
Colwell J A, Halushka P V, Sarji K, Levin J, Sagel J, Nair R M G (1976) Altered platelet function in diabetes mellitus. Diabetes 25:826–831
Halushka P V, Lurie D, Colwell J A (1977) Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus. N Engl J Med 297:1306–1310
Kohner E M (1978) The evolution and natural history of diabetic retinopathy. In: Kohner EM (ed) Diabetic retinopathy. Int. Opthalm. Clin. Little Brown & Co., Boston, p 1–16
McMillan D C, Oliver M R (1965) The initial changes in platelet morphology following the addition of adenosine diphosphate. J Atheroscl Res 5:440–444
Ferguson J C, Mackay N, Philip JAD, Sumner D J (1975) Determination of platelet and fibrinogen half-life with 75Seleniomethionine: studies in normal and in diabetic subjects. Clin Sci Mol Med 49:115–120
Bern M M (1978) Platelet function in diabetes mellitus. Diabetes 27:342–350
Burrows A W, Chavin S I, Hockaday T D R (1978) Plasma β-thromboglobulin concentrations in diabetes mellitus. Lancet I:235–237
Petersen H D, Gormsen J (1978) Platelet aggregation in diabetes mellitus. Acta Med Scand 203:125–130
Campbell I W, Dawes J, Fraser D M, Pepper D S, Clarke B F, Duncan L J, Cash J D (1977) Plasma beta-thromboglobulin in diabetes mellitus. Diabetes 26:1175–1177
Karpatkin S, Langer RM (1968) Biochemical energetics of stimulated platelet plug formation. Effect of thrombin, adenosine diphosphate and epinephrine on intra and extracellular adenine nucleotide kinetics. J Clin Invest 47:2158–2168
Zucker M B, Zaccardi J B (1964) Platelet shape change induced by adenosine diphosphate and prevented by adenosine monophosphate. Fed Proc 23:299
Ehrman M, Toth E, Frajmovic M (1976) A platelet procoagulant activity associated with platelet shape change. J Lab Clin Med 87:909–912
Born G V R, Dearnley R, Foulks J G, Sharp D E (1978) Quantification of the morphological reaction of platelets to aggregating agents and of its reversal by aggregation inhibitors. J Physiol (Lond) 280:193–212
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Porta, M., Hilgard, P. & Kohner, E.M. Platelet shape change abnormalities in diabetic retinopathy. Diabetologia 18, 217–221 (1980). https://doi.org/10.1007/BF00251919
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00251919